April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Neuroprotective Effect of Intravitreal Cell-Based Glucagon-Like Peptide-1 Production in the Optic Nerve Crush Model
Author Affiliations & Notes
  • J. B. Jonas
    Ophthalmology, Fac Clin Med Mannheim-Heidelberg, Mannheim, Germany
  • R. Zhang
    Ophthalmology, Beijing Institute of Ophthalmology, Beijing, China
  • H. Zhang
    Ophthalmology, Beijing Institute of Ophthalmology, Beijing, China
  • L. Xu
    Ophthalmology, Beijing Institute of Ophthalmology, Beijing, China
  • K. Ma
    Ophthalmology, Beijing Institute of Ophthalmology, Beijing, China
  • C. Wallrapp
    CellMed Ag, Alzenau, Germany
  • Footnotes
    Commercial Relationships  J.B. Jonas, MSD, Zeiss Meditec, CellMed AG,Allergan, C; CellMed AG, Alzenau, P; MSD, Pfizer, Allergan, Zeiss Meditec, R; R. Zhang, None; H. Zhang, None; L. Xu, None; K. Ma, None; C. Wallrapp, CellMed AG Alzenau, E; CellMed AG Alzenau, P.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2520. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. B. Jonas, R. Zhang, H. Zhang, L. Xu, K. Ma, C. Wallrapp; Neuroprotective Effect of Intravitreal Cell-Based Glucagon-Like Peptide-1 Production in the Optic Nerve Crush Model. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2520.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the effect of intraocularly produced glucagon-like peptide-1 (GLP-1) on the survival rate of retinal ganglion cells in the optic nerve crush model.

Methods: : Forty-one Sprague-Dawley rats were divided into a study group (21 animals) in which 4 beads with 3000 genetically modified cells to produce GLP-1 were intravitreally implanted into the right eye; a saline control group (n=12) with intravitreal saline injection into the right eye; and a GLP-1 negative bead control group (n=8) in which 4 beads with 3000 cells without GLP-1 production were intravitreally implanted into the right eye. The right optic nerves of all animals were crushed in a standardized manner. After labeling the retinal ganglion cells by injecting 3% fluorogold into the superior colliculus, the animals were sacrificed, and the ganglion cells were counted on retinal flat mounts.

Results: : The retinal ganglion cell density of the right eyes was significantly higher in the study group (2030±470 cells/mm2) than in the GLP-1 bead negative control group (1390±367 cells/mm2; P=0.001) and than in the saline control group (1734±424 cells/mm2; P=0.07). Correspondingly, the survival rate (ratio of retinal ganglion cell density of right eye / left eye) was significantly higher in the study group (71±19%) than in the GLP-1 bead negative control group (49±14%; P=0.003) and than in the saline control group (57±16%; P=0.03).

Conclusions: : Glucagon-like peptide-1 produced locally by intravitreally implanted cell beads was associated with a higher survival rate of retinal ganglion cells after an experimental and standardized optic nerve crush in rats.

Keywords: optic nerve • optic disc • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×